Literature DB >> 19648956

Before it's too late. Why synthetic biologists need an open-parts collaboration--and how to build one.

Stephen M Maurer1.   

Abstract

Mesh：

Year:  2009        PMID： 19648956      PMCID： PMC2726678          DOI： 10.1038/embor.2009.165

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  3 in total

1.  The economics of follow-on drug research and development: trends in entry rates and the timing of development.

Authors:  Joseph A DiMasi; Cherie Paquette
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Biotech patents-business as usual?

Authors:  Stacy Lawrence
Journal:  Nat Biotechnol       Date:  2008-12       Impact factor: 54.908

3.  The economics of synthetic biology.

Authors:  Joachim Henkel; Stephen M Maurer
Journal:  Mol Syst Biol       Date:  2007-06-05       Impact factor: 11.429
  3 in total
  2 in total

1.  New approaches to rewarding pharmaceutical innovation.

Authors:  Paul Grootendorst; Aidan Hollis; David K Levine; Thomas Pogge; Aled M Edwards
Journal:  CMAJ       Date:  2010-12-13       Impact factor: 8.262

2.  Parts, property and sharing.

Authors:  Joachim Henkel; Stephen M Maurer
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.